Dr. Michele Kong, MD
Claim this profileThe University of Alabama at Birmingham
Studies Respiratory Syncytial Virus
Studies Respiratory Insufficiency
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Michele Kong, MD is currently running
Azithromycin
for RSV-Induced Respiratory Failure
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
Recruiting1 award Phase 35 criteria
Enoxaparin
for Blood Clot Prevention
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Recruiting1 award Phase 2 & 33 criteria
More about Michele Kong, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michele Kong, MD has experience with
- Azithromycin
- Therapeutic Hypothermia
- Enoxaparin
Breakdown of trials Michele Kong, MD has run
Respiratory Syncytial Virus
Respiratory Insufficiency
Brain Ischemia
Hypothermia
Cardiac Arrest
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michele Kong, MD specialize in?
Michele Kong, MD focuses on Respiratory Syncytial Virus and Respiratory Insufficiency. In particular, much of their work with Respiratory Syncytial Virus has involved treating patients, or patients who are undergoing treatment.
Is Michele Kong, MD currently recruiting for clinical trials?
Yes, Michele Kong, MD is currently recruiting for 3 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Michele Kong, MD has studied deeply?
Yes, Michele Kong, MD has studied treatments such as Azithromycin, Therapeutic Hypothermia, Enoxaparin.
What is the best way to schedule an appointment with Michele Kong, MD?
Apply for one of the trials that Michele Kong, MD is conducting.
What is the office address of Michele Kong, MD?
The office of Michele Kong, MD is located at: The University of Alabama at Birmingham, Birmingham, Alabama 35233 United States. This is the address for their practice at the The University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.